Wockhardt hosts visit of Prime Minister of United Kingdom

Wockhardt, the global pharmaceutical and biotechnology major, on 30th November, hosted a visit at its Wrexham facility in North Wales of the Prime Minister of the United Kingdom, Mr. Boris Johnson.

The Prime Minister inspected the Wockhardt’s fill-finish production line and was accompanied by local Wrexham Conservative MP Sarah Atherton.

The  UK  Government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.

Prime Minister Boris Johnson said: “Today marks the next stage in the UK distribution of the coronavirus vaccine.”
“Our agreement with Wockhardt is a significant milestone for the British life science industry and will help produce the vaccines this country needs”.

“I am grateful to have met with some of the hardworking team here in Wales, who are helping take us one step closer to defeating this virus.”

While acknowledging the visit as a mark of Honour, the Founder Chairman of Wockhardt Dr. Habil Khorakiwala said, “The visit today, 30th November, by the Prime Minister of UK demonstrates our global strength in sterile injectable facilities and capacity.  With four decades of expertise and experience behind us, we are able to quickly rise to the occasion, scale up the manufacture of much-desired vaccines, and assist in mitigating the global impact of COVID-19. We have more than a billion dosage capacity  for  both  API  &  fill-finish  globally  and  can  be a partner  to  fight  the  world’s  most demanding need of the hour in COVID-19.”

Wockhardt is a global pharmaceutical and biotech organisation that brings affordable, high-quality medicines to market. As a global organisation, Wockhardt is focussed and committed to assisting in mitigating the worldwide impact of COVID-19, and the collaboration with the UK Government to make vaccines available upholds its the ongoing commitment to fighting against such a pandemic of global human importance. In the UK, Wockhardt is one of the largest suppliers of the NHS for over  20 years,  has had a presence in Wrexham for over two decades, and employs over  400  people at its 612,000  square feet high-tech manufacturing facility.

Speaking about the visit Ravi Limaye, Managing Director Wockhardt UK said, “We are privileged to host the Prime Minister and showcase our world-class manufacturing capability here in Wrexham.

Our sophisticated  sterile  facility  and  highly  skilled  workforce  are  a  prime  example  of  why  the manufacturing sector is a major employer accounting for around 9% of the UK workforce.”